Effectiveness of Cannabidiol Vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery
- Registration Number
- NCT05240755
- Brief Summary
This study is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Age 18 years or older
- Requiring shoulder arthroscopic surgery for soft tissue pathology
- Able to complete surveys and follow-up visits
Exclusion Criteria
- Younger than 18 years of age
- Shoulder dislocation, fracture, previous surgery, coexisting extremity pathology, pregnancy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cannabidiol Oil 100 mg Cannabidiol Oil CBD 100 mg PO liquid suspension QD starting 30 days prior and finishing 30 days post-op Cannabidiol Oil 200 mg Cannabidiol Oil CBD 200 mg PO liquid suspension QD starting 30 days prior and finishing 30 days post-op
- Primary Outcome Measures
Name Time Method Post-operative pain 30 days post-operatively Numerical Pain Scale (NRS): 0 being no pain, 10 being the worst pain imaginable. Higher scores are worse outcomes.
- Secondary Outcome Measures
Name Time Method Sleep Quality 30 days preoperatively leading up to surgery then 30 days postoperatively as well. Outcomes will be collected from surgery to 6 weeks postoperatively. Insomnia Severity Index
Trial Locations
- Locations (1)
Florida Orthopaedic Institute
🇺🇸Tampa, Florida, United States
Florida Orthopaedic Institute🇺🇸Tampa, Florida, United States